feed,title,long_url,short_url
Benzinga,Novartis' Iptacopan Meets Primary Endpoint Goal In Rare Kidney Disease Trial,https://benzinga.com/general/biotech/21/11/23901473/novartis-iptacopan-meets-primary-endpoint-goal-in-rare-kidney-disease-trial,https://j.mp/3k8SPWh
